More reads
- A hallucinogenic root is pitched to Davos set as treatment for opioid addiction. (Bloomberg)
- Civica Rx teams with Blue Cross Blue Shield to widen its alternative market for generics (STAT Plus)
- The phenom of Big Pharma says ‘self-disruption’ is key to success as a CEO. (Fast Company)
- European Court adviser deals Glaxo a setback in 'pay-to-delay' case. (STAT Plus)
No hay comentarios:
Publicar un comentario